The Zhengzhou Yumei Cancer Hospital International Alliance serves as the core platform for cancer diagnosis, treatment, and technological transformation for the Sino-US Saiaojin Cancer Chain Group's expansion into the Central Plains and nationwide reach. Leveraging the group's global biomedical resources and core cell therapy technology, the alliance focuses on precision cancer diagnosis and treatment, clinical translation of cutting-edge technologies, and international medical collaborations. It is committed to establishing a benchmark in cancer healthcare that is domestically leading and aligned with international standards.